| Date Filed | Type | Description |
| 10/04/2023 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 8,549 shares
@ $3.83, valued at
$32.7k
|
|
| 07/05/2023 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 981 shares
@ $4.1, valued at
$4k
|
|
| 06/02/2023 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Granted 2,766 shares
@ $3.4563, valued at
$9.6k
|
|
| 04/04/2023 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 2,734 shares
@ $3.08, valued at
$8.4k
|
|
| 01/04/2023 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 10,685 shares
@ $0.15, valued at
$1.6k
|
|
| 12/02/2022 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Granted 34,705 shares
@ $0.1977, valued at
$6.9k
|
|
| 10/04/2022 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 10,683 shares
@ $0.223, valued at
$2.4k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 23,186 shares
@ $0.65, valued at
$15.1k
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Granted 4,263 shares
@ $1.445, valued at
$6.2k
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2020 |
4
| Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Bought 75,000 shares
@ $1.3809, valued at
$103.6k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| Domzalski David (President and CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 680,000 shares
@ $0
Granted 680,000 options
@ $1.95, valued at
$1.3M
|
|
| 04/07/2020 |
4
| Domzalski David (President and CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 141,901 shares
@ $0
Granted 249,588 shares
@ $0
Paid exercise price by delivering 11,772 shares
@ $1.4, valued at
$16.5k
|
|
| 04/02/2020 |
4
| Domzalski David (President and CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 4,456 shares
@ $2.68, valued at
$11.9k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 9,842 shares
@ $2.159, valued at
$21.2k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|